Zdrowie i gospodarka · 18/07/2006

Guidance on Useful Written Consumer Medication Information; Availability

The Food and Drug Administration (FDA) is announcing the availability of a guidance entitled "Useful Written Consumer Medication Information (CMI)." CMI is written information developed for consumers about prescription drugs that is distributed to consumers when they have prescriptions filled. The guidance discusses general issues and makes recommendations on the content of useful written CMI.